78 related articles for article (PubMed ID: 20622331)
1. [Expression of galectin-3 and Sambucus nigra agglutinin and its clinicopathological significance in benign and malignant lesions of breast].
Chen G; Zou Q; Yang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Jun; 35(6):584-9. PubMed ID: 20622331
[TBL] [Abstract][Full Text] [Related]
2. [Expression of galectin 3 and Sambucus nigra agglutinin and their clinicopathological significance in benign and malignant lesions of stomach].
Zhou JP; Yang ZL; Liu DC; Zhou JP
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):297-300. PubMed ID: 19434543
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of galectin-3 and Sambucus nigra agglutinin binding site is associated with invasion, metastasis and poor-progression of the gallbladder adenocarcinoma.
Yang LP; Jiang S; Liu JQ; Miao XY; Yang ZL
Hepatogastroenterology; 2012 Oct; 59(119):2089-94. PubMed ID: 22497866
[TBL] [Abstract][Full Text] [Related]
4. Carbohydrate-binding activity of the type-2 ribosome-inactivating protein SNA-I from elderberry (Sambucus nigra) is a determining factor for its insecticidal activity.
Shahidi-Noghabi S; Van Damme EJ; Smagghe G
Phytochemistry; 2008 Dec; 69(17):2972-8. PubMed ID: 18951590
[TBL] [Abstract][Full Text] [Related]
5. Internalization of Sambucus nigra agglutinins I and II in insect midgut CF-203 cells.
Shahidi-Noghabi S; Van Damme EJ; De Vos WH; Smagghe G
Arch Insect Biochem Physiol; 2011 Apr; 76(4):211-22. PubMed ID: 21254203
[TBL] [Abstract][Full Text] [Related]
6. Construction and validation of a Sambucus nigra biosensor for cancer-associated STn antigen.
Silva ML; Gutiérrez E; Rodríguez JA; Gomes C; David L
Biosens Bioelectron; 2014 Jul; 57():254-61. PubMed ID: 24594592
[TBL] [Abstract][Full Text] [Related]
7. [Steroid hormone receptors in the normal breast and in benign mastopathies].
Kouyoumdjian JC; Feuilhade F; Pinaudeau Y; Rymer JC
Bull Cancer; 1986; 73(2):120-3. PubMed ID: 3730631
[No Abstract] [Full Text] [Related]
8. Lectin binding patterns in benign and malignant lesions of the breast.
Karuna V; Shanthi P; Madhavan M
Indian J Pathol Microbiol; 1992 Oct; 35(4):289-97. PubMed ID: 1344218
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for sugar recognition, including the Tn carcinoma antigen, by the lectin SNA-II from Sambucus nigra.
Maveyraud L; Niwa H; Guillet V; Svergun DI; Konarev PV; Palmer RA; Peumans WJ; Rougé P; Van Damme EJ; Reynolds CD; Mourey L
Proteins; 2009 Apr; 75(1):89-103. PubMed ID: 18798567
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of acute-phase reactant proteins in sera and breast lesions of patients with malignant and benign breast tumors.
Doustjalali SR; Yusof R; Yip CH; Looi LM; Pillay B; Hashim OH
Electrophoresis; 2004 Jul; 25(14):2392-401. PubMed ID: 15274022
[TBL] [Abstract][Full Text] [Related]
11. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer.
Logullo AF; Lopes AB; Nonogaki S; Soares FA; Netto MM; Nishimoto IN; Brentani MM
Oncol Rep; 2007 Jul; 18(1):121-6. PubMed ID: 17549356
[TBL] [Abstract][Full Text] [Related]
12. Identification of galectin-3 and mucin-type O-glycans in breast cancer and its metastasis to brain.
Mayoral MA; Mayoral C; Meneses A; Villalvazo L; Guzman A; Espinosa B; Ochoa JL; Zenteno E; Guevara J
Cancer Invest; 2008 Jul; 26(6):615-23. PubMed ID: 18584353
[TBL] [Abstract][Full Text] [Related]
13. Expression of oestrogen receptor alpha variants in non-malignant breast and early invasive breast carcinomas.
Chappell SA; Johnson SM; Shaw JA; Walker RA
J Pathol; 2000 Oct; 192(2):159-65. PubMed ID: 11004691
[TBL] [Abstract][Full Text] [Related]
14. Expression of the apoptotic markers in normal breast epithelium, benign mammary dysplasia and in breast cancer.
Koda M; Kanczuga-Koda L; Reszec J; Sulkowska M; Famulski W; Baltaziak M; Kisielewski W; Sulkowski S
Folia Morphol (Warsz); 2004 Aug; 63(3):337-41. PubMed ID: 15478112
[TBL] [Abstract][Full Text] [Related]
15. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
[TBL] [Abstract][Full Text] [Related]
16. Jack fruit lectin binding pattern in benign and malignant lesions of the breast.
Remani P; Augustine J; Vijayan KK; Ankathil R; Vasudevan DM; Nair MK; Vijayakumar T
In Vivo; 1989; 3(4):275-8. PubMed ID: 2519866
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of E-cadherin in sclerosing adenosis, ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Facina G; Lopes-Costa PV; Dos Santos AR; De Vasconcelos-Valença RJ; Pinho-Sobral AL; Ferreira-Filho CP; Alencar AP; Gebrim LH; Da Silva BB
Diagn Cytopathol; 2010 Apr; 38(4):235-8. PubMed ID: 19790246
[TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical detection of the estrogen receptor in benign tumors of the breast and in forms of mastopathy].
Köhler G; Bässler R
Pathologe; 1987 Nov; 8(6):325-33. PubMed ID: 3321027
[No Abstract] [Full Text] [Related]
19. [Immunohistochemical localization of protein S-100 in myoepithelial cells of the breast in healthy and pathologic conditions].
Lanzafame S; Puzzo L
Pathologica; 1986; 78(1056):435-49. PubMed ID: 3615022
[No Abstract] [Full Text] [Related]
20. p53 expression in cytologic specimens from benign and malignant breast lesions.
Koutselini H; Malliri A; Field JK; Spandidos DA
Anticancer Res; 1991; 11(4):1415-9. PubMed ID: 1746898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
